Background: The skin diseases are affected by various factors. The rural population is more vulnerable because of illiteracy. Therefore an attempt has been made to screen the population of five villages to know pattern of skin diseases. Aims of the study were to assess the prevalence of skin diseases, determine the pattern of skin diseases in the study population in rural community of Medchal mandal and compare previous studies so that inferences can be drawn for the benefit of society. Methods: The study was aimed to include the total population of 5930 consisting of 5 villages. The present study was carried out during a period of one and half year in 5 villages of Medchal mandal. The total population of all the 5 villages comprises of 7726, out of which 5930 persons participated in the present study. In all villages house to house survey was done. A complete dermatological assessment of the study population was done and findings were recorded on the standard study proforma. Results: The total number of 5930 persons was screened during the period of study. Among which 1172 (19.76%) persons were noted to have skin diseases. out of which 533 (45.48%) were males and 639 (54.52%) were females. The majority of population with skin disease was in the age group of 31-40 years with 289 cases (24.65%) and least in 71-80 age groups with 7 cases (0.59%). The prevalence of Non-infectious diseases (705 cases, 60.15%) was more than that of Infectious diseases (467 cases, 39.85%). Among non-infectious conditions Eczema / Allergy was the common disease followed by Pigmentary disorders other conditions like alopecia areata, seborrheic dermatitis and senile xerosis, Papulosquamous disorders, acne and acneiform dermatoses, polymorphous light eruptions and bite and stings, Eczemas followed by lichen simplex chronicus and allergic contact dermatitis. Among infectious conditions, bacterial infections were most common diseases followed by parasitic infestations, fungal infections and viral infections. Among Bacterial infections, secondary Pyodermas followed by folliculitis, impetigo and furunculosis. Based on occupation the majority of population was in the students followed by farmers, labour other than agriculture, housewives and petty business. Based on education, the majority of population was in the primary group (class 1 to 5) followed by secondary (class 6 to 8) and high school and above. Conclusions: Based on the outcome of this study, the common skin problems existing in this area are to be carefully looked for and health education regarding the hygiene, nutrition and healthy life styles is to be stressed for better standard of living by the rural population.

No abstract

the study and involved in manuscript editing. R.N. and J.B. had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

<p class="abstract"><strong>Background:</strong> Eberconazole, a newer Imidazole derivative, antimycotic drug. Similarly, sertaconazole and luliconazole are also newer antifungal which all exhibit fungicidal, fungistatic and anti-inflammatory actions. But, sertaconazole in addition have antipruritic effect also.</p><p class="abstract"><strong>Methods:</strong> Randomized, open-labelled, prospective study comprising of 75 patients divided into three equal groups A, B, C of 25 patients each. Group A received eberconazole 1%, Group B received sertaconazole 2% and Group C received luliconazole 1% for twice daily topical application for 4 weeks. Patients were asked to review at 2^nd and 4^th week to record clinical and mycological cure.<strong></strong></p><p class="abstract"><strong>Results:</strong> In this study out of 75, seventy patients completed the complete course of treatment whereas, five patients were not reported for review citing personal reasons. Parameters included are pruritus, erythema, scaling and vesicles in all three groups. In this study, marked relief of pruritus was achieved clinically with eberconazole (72.7%) followed by luliconazole and sertaconazole with 50.0% and 33.3% respectively at 4^th week of treatment phase and reduction of scaling was achieved more with eberconazole (90.9%), sertaconazole (87.5%) and luliconazole (83.3%). All three groups of patients showed successful mycological cure by confirming with negative 10% potassium hydroxide examination at the end of treatment course.</p><p class="abstract"><strong>Conclusions:</strong> Eberconazole 1% cream was better than sertaconazole 2% cream and luliconazole 1% cream in relieving symptoms like pruritus and scaling at the end of treatment phase and follow up.</p>

No abstract